Sante Ventures

Type

Venture Capital

Status

Active

Location

Austin, United States

Total investments

92

Average round size

11M

Portfolio companies

46

Rounds per year

5.11

Lead investments

27

Follow on index

0.50

Exits

12

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHospitalManufacturingMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharmaClinical Trials

Summary

Sante Ventures is the famous VC, which was founded in 2007. The venture was found in North America in United States. The main office of represented VC is situated in the Austin.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Sante Ventures, startups are often financed by Prolog Ventures, ONSET Ventures, Highland Capital Partners. The meaningful sponsors for the fund in investment in the same round are Austin Ventures, MB Venture Partners, Prolog Ventures. In the next rounds fund is usually obtained by Square 1 Bank, Prolog Ventures, Austin Ventures.

The top activity for fund was in 2013. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Sante Ventures performs on 7 percentage points less the average number of lead investments. The top amount of exits for fund were in 2018. The real fund results show that this VC is 57 percentage points more often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Lumos Pharma, Zeno Corporation, EndoStim. The fund has exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The overall number of key employees were 4.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesMedtechHealthcare
Stage focus
SeedSeries ASeries B
Geo focus
United States
Check size
5M — 8M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 260000000
Fund raised date
2021-09-16

Analytics

Total investments
92
Lead investments
27
Exits
12
Rounds per year
5.11
Follow on index
0.50
Investments by industry
  • Health Care (68)
  • Biotechnology (44)
  • Therapeutics (30)
  • Medical (29)
  • Medical Device (25)
  • Show 29 more
Investments by region
  • United States (89)
  • Canada (2)
  • New Zealand (1)
Peak activity year
2013

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
20M
Group Appearance index
0.61
Avg. company exit year
9
Avg. multiplicator
4.63
Strategy success index
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Geneos Therapeutics 24 Mar 2022 Biotechnology, Health Care, Pharmaceutical, Therapeutics Early Stage Venture 17M United States, Pennsylvania, Whitemarsh Township
Reprieve Cardiovascular 20 Feb 2024 Health Care, Wellness, Medical Device Early Stage Venture 42M United States, Massachusetts

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.